We are live on ! Find out more
SAM

Smithbridge Asset Management Portfolio holdings

AUM $674M
1-Year Est. Return 26.11%
This Fund
S&P 500
This Quarter Est. Return
+3.46%
1 Year Est. Return
+26.11%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$121M
AUM Growth
+$7.16M
Cap. Flow
+$3.97M
Cap. Flow %
3.27%
Top 10 Hldgs %
35.71%
Holding
70
New
12
Increased
26
Reduced
24
Closed
5

Top Buys

Rank Stock Value
1
IDCC icon
InterDigital
IDCC
+$3.85M
2
MCK icon
McKesson
MCK
+$1.2M
3
NVS icon
Novartis
NVS
+$667K
4
NVO
Novo Nordisk
NVO
+$622K
5
TROW icon
T. Rowe Price
TROW
+$563K

Sector Composition

Rank Sector Weight
1 Technology 26.26%
2 Healthcare 20.3%
3 Industrials 16.36%
4 Financials 9.37%
5 Consumer Discretionary 6.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABBV icon
26
AbbVie
ABBV
$450B
$2.2M 1.81%
30,321
-3,690
-11% -$248K
SLB icon
27
SLB Ltd
SLB
$70.3B
$2.03M 1.67%
30,786
+380
+1% +$27.2K
SYK icon
28
Stryker
SYK
$123B
$1.93M 1.59%
13,928
+140
+1% +$19.2K
DIS icon
29
Walt Disney
DIS
$170B
$1.85M 1.53%
17,460
+100
+0.6% +$10.9K
VZ icon
30
Verizon
VZ
$182B
$1.84M 1.52%
41,317
-400
-1% -$18.6K
INTC icon
31
Intel
INTC
$478B
$1.68M 1.38%
49,689
+5,032
+11% +$180K
GS icon
32
Goldman Sachs
GS
$314B
$1.64M 1.35%
7,375
-100
-1% -$22.2K
FISV
33
Fiserv Inc
FISV
$27B
$1.61M 1.32%
26,250
-960
-4% -$58.1K
CVX icon
34
Chevron
CVX
$373B
$1.47M 1.21%
14,126
-513
-4% -$54.3K
TEVA icon
35
Teva Pharmaceuticals
TEVA
$37.3B
$1.35M 1.11%
40,551
+4,281
+12% +$133K
QCOM icon
36
Qualcomm
QCOM
$181B
$1.34M 1.11%
24,366
-230
-0.9% -$12.8K
UL icon
37
Unilever
UL
$134B
$1.31M 1.08%
21,449
+338
+2% +$20.1K
MCK icon
38
McKesson
MCK
$98.5B
$1.3M 1.07%
+7,884
New +$1.2M
MET icon
39
MetLife
MET
$60.5B
$1.26M 1.04%
25,781
+3,927
+18% +$182K
CVS icon
40
CVS Health
CVS
$137B
$1.23M 1.01%
15,280
+1,960
+15% +$155K
VAR
41
DELISTED
Varian Medical Systems, Inc.
VAR
$1.21M 1%
11,750
-19,025
-62% -$1.83M
KMB icon
42
Kimberly-Clark
KMB
$36B
$1.11M 0.91%
8,600
-550
-6% -$71.6K
BNS icon
43
Scotiabank
BNS
$110B
$1.09M 0.9%
18,165
+555
+3% +$31.8K
EPD icon
44
Enterprise Products Partners
EPD
$82.6B
$1.04M 0.86%
38,492
-985
-2% -$26.7K
EEM icon
45
iShares MSCI Emerging Markets ETF
EEM
$28B
$931K 0.77%
22,500
-50
-0.2% -$2.04K
GE icon
46
GE Aerospace
GE
$364B
$845K 0.7%
6,524
+2,091
+47% +$287K
IDV icon
47
iShares International Select Dividend ETF
IDV
$8.28B
$802K 0.66%
24,500
-200
-0.8% -$6.48K
NVS icon
48
Novartis
NVS
$293B
$703K 0.58%
+9,406
New +$667K
ITW icon
49
Illinois Tool Works
ITW
$79.4B
$696K 0.57%
4,860
VIG icon
50
Vanguard Dividend Appreciation ETF
VIG
$111B
$610K 0.5%
6,585
+2,085
+46% +$191K

Similar funds

Smithbridge Asset Management's Q2 2017 Portfolio in Review

As of Q2 2017, Smithbridge Asset Management held 70 positions worth $121M, up 6.3% from $114M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Smithbridge Asset Management deployed $3.97M of net new capital in Q2 2017, opening 12 new positions and adding to 26 existing holdings. Its largest new stake was InterDigital: 46,000 shares worth $3.56M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Varian Medical Systems, Inc., an estimated $1.83M trimmed.

  • Smithbridge Asset Management's largest Q2 2017 buy was InterDigital: 46,000 shares worth $3.56M.
  • Smithbridge Asset Management added most to Novo Nordisk in Q2 2017, an estimated $622K increase.
  • Smithbridge Asset Management's biggest Q2 2017 reduction was Varian Medical Systems, Inc., cutting an estimated $1.83M.
  • Smithbridge Asset Management fully exited Nuveen Preferred & Income Opportunities Fund in Q2 2017, selling an estimated $2.68M.
  • Smithbridge Asset Management's ten largest holdings make up 36% of its $121M portfolio in Q2 2017.
  • Smithbridge Asset Management opened 12 new positions and closed 5 in Q2 2017.
  • Smithbridge Asset Management's portfolio value rose 6.3% quarter-over-quarter to $121M.

Based on Smithbridge Asset Management's 13F filing for Q2 2017, filed 17 Jul 2017.